Emerging tools for stroke prevention in atrial fibrillation

Christos Voukalis; Gregory Y.h. Lip; Eduard Shantsila

doi:10.1016/j.ebiom.2016.01.017

Emerging tools for stroke prevention in atrial fibrillation

Christos Voukalis, Gregory Y.h. Lip, Eduard Shantsila

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Abstract

Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke prevention requires the use of the vitamin K antagonists or non-vitamin K oral anticoagulants (NOACs). This article summarises the latest developments in the field of stroke prevention in AF and aims to assist physicians with the choice of oral anticoagulant for patients with non-valvular AF with different risk factor profile.

Original language	English
Pages (from-to)	26–39
Journal	EBioMedicine
Volume	4
Early online date	15 Jan 2016
DOIs	https://doi.org/10.1016/j.ebiom.2016.01.017
Publication status	Published - Feb 2016

Keywords

Atrial fibrillation
Stroke prevention
Oral anticoagulation
Risk stratification
Non-vitamin K oral anticoagulants
Net clinical benefit

Access to Document

10.1016/j.ebiom.2016.01.017Licence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

Cite this

@article{43a097c9e39940f1a79ec41f3183df2a,

title = "Emerging tools for stroke prevention in atrial fibrillation",

abstract = "Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke prevention requires the use of the vitamin K antagonists or non-vitamin K oral anticoagulants (NOACs). This article summarises the latest developments in the field of stroke prevention in AF and aims to assist physicians with the choice of oral anticoagulant for patients with non-valvular AF with different risk factor profile.",

keywords = "Atrial fibrillation, Stroke prevention , Oral anticoagulation, Risk stratification, Non-vitamin K oral anticoagulants, Net clinical benefit",

author = "Christos Voukalis and Lip, {Gregory Y.h.} and Eduard Shantsila",

year = "2016",

month = feb,

doi = "10.1016/j.ebiom.2016.01.017",

language = "English",

volume = "4",

pages = "26–39",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier",

}

TY - JOUR

T1 - Emerging tools for stroke prevention in atrial fibrillation

AU - Voukalis, Christos

AU - Lip, Gregory Y.h.

AU - Shantsila, Eduard

PY - 2016/2

Y1 - 2016/2

N2 - Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke prevention requires the use of the vitamin K antagonists or non-vitamin K oral anticoagulants (NOACs). This article summarises the latest developments in the field of stroke prevention in AF and aims to assist physicians with the choice of oral anticoagulant for patients with non-valvular AF with different risk factor profile.

AB - Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke prevention requires the use of the vitamin K antagonists or non-vitamin K oral anticoagulants (NOACs). This article summarises the latest developments in the field of stroke prevention in AF and aims to assist physicians with the choice of oral anticoagulant for patients with non-valvular AF with different risk factor profile.

KW - Atrial fibrillation

KW - Stroke prevention

KW - Oral anticoagulation

KW - Risk stratification

KW - Non-vitamin K oral anticoagulants

KW - Net clinical benefit

U2 - 10.1016/j.ebiom.2016.01.017

DO - 10.1016/j.ebiom.2016.01.017

M3 - Article

SN - 2352-3964

VL - 4

SP - 26

EP - 39

JO - EBioMedicine

JF - EBioMedicine

ER -

Emerging tools for stroke prevention in atrial fibrillation

Abstract

Keywords

Access to Document

Fingerprint

Cite this